Lifecore Biomedical, Inc. De (LFCR) Change in Receivables (2010 - 2025)

Lifecore Biomedical's Change in Receivables history runs 16 years deep, the most recent figure standing at $1.7 million for Q2 2025.

• In Q2 2025, Change in Receivables rose 200.72% year-over-year to $1.7 million; the TTM figure through May 2025 stood at $4.6 million (up 40.21% YoY), while the FY2025 annual figure was $2.3 million, down 30.68% from the prior year.
• Change in Receivables was $1.7 million for Q2 2025 at Lifecore Biomedical, down from $3.2 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $16.1 million in Q4 2023 to a low of -$11.0 million in Q2 2023.
• Historically, Change in Receivables has averaged -$456500.0 across 5 years, with a median of $561000.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Change in Receivables jumped 882.08% in 2021, then tumbled 1420.18% in 2022.
• A 5-year view of Change in Receivables shows it stood at $3.5 million in 2021, then slumped by 251.77% to -$5.2 million in 2022, then jumped by 407.0% to $16.1 million in 2023, then slumped by 64.23% to $5.8 million in 2024, then tumbled by 71.18% to $1.7 million in 2025.
• The last three Change in Receivables figures came in at $1.7 million (Q2 2025), $3.2 million (Q1 2025), and $5.8 million (Q4 2024), per Business Quant data.